Deutsche Bank raised the firm’s price target on HealthEquity to $72 from $71 and keeps a Buy rating on the shares following the Q2 beat.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HQY:
- HealthEquity price target raised to $85 from $80 at Barrington
- HealthEquity price target raised to $77 from $75 at RBC Capital
- HealthEquity raises FY24 EPS view to $1.97-$2.06 from $1.88-$1.97
- HealthEquity Reports Second Quarter Ended July 31, 2023 Financial Results
- HealthEquity reports Q2 EPS 53c, consensus 48c